Singapore: Australia's Allied Healthcare Group has successfully completed an oversubscribed strategic placement which ra...
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...
Singapore: ASX-listed Living Cell Technologies has appointed Dr Andrea Grant to the board as managing director. Mr Roy A...
Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...
Bangalore: Australian drug delivery technology company Phosphagenics has licensed an injectable antibiotic product, har...
Singapore: Bionomics presented an update on its renal cancer candidate's (BNC105) clinical trial program at the annual A...
Contrast induced nephropathy (CIN) is a form of kidney damage caused by the toxic effects of dyes (contrast) used by car...
Singapore: Prana Biotechnology, listed with the ASX, has reported progress in the phase II clinical trials with its lead...
Singapore: A team of cancer scientists from The University of Western Australia (UWA) have found that the gene known to ...
Singapore: The US has been making several modifications to its patent laws lately and this is impacting the global biote...
Singapore: Australia-based medical technology company iSonea has completed testing and technical documentation for the A...
Singapore: Australia-based Bionomics' CEO, Dr Deborah Rathjen, has provided an update about the company at the Biotech...
‎Singapore: Supply chain firm, Marken has appointed Mr Michael Culme-Seymour as VP, Asia Pacific, effective Octobe...
Singapore: Silence Therapeutics, a leading RNA interference (RNAi) therapeutics company based in the UK, has signed an a...
Singapore: Allied Healthcare has announced that its Herpes Simplex Virus (HSV-2) vaccine has received ethical approval t...
Singapore: UniQuest has partnered with US-based Emory University to package biotech assets for a new start-up company fr...
Singapore: The director and CEO of Australia's largest virology and communicable disease research center, Burnet Institu...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem's novel antimicrobial (BDM-I) w...
